Victoria M. Smith
Leicester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
The BH3-only protein NOXA is essential for apoptosis induction by BH3-mimetics targeting BCL2 or BCL-XL in DLBCL.
Journal: British journal of haematology
Published: May 23, 2025
In vitro comparison of CD20xCD3 bispecific antibodies against diffuse large B-cell lymphoma (DLBCL) cell lines with different levels of expression of CD20.
Journal: British journal of haematology
Published: November 28, 2024
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy.
Journal: Signal transduction and targeted therapy
Published: November 07, 2024
Identification of a novel form of caspase-independent cell death triggered by BH3-mimetics in diffuse large B-cell lymphoma cell lines.
Journal: Cell death & disease
Published: September 04, 2023
Computational modeling of DLBCL predicts response to BH3-mimetics.
Journal: NPJ systems biology and applications
Published: February 26, 2023
BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib.
Journal: Blood advances
Published: November 21, 2022
Successful Retreatment With Venetoclax in a Patient With Chronic Lymphocytic Leukemia.
Journal: HemaSphere
Published: April 28, 2022
poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells.
Journal: Translational oncology
Published: January 25, 2022
Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker.
Journal: Scientific reports
Published: October 21, 2020
DLBCL Cells with Acquired Resistance to Venetoclax Are Not Sensitized to BIRD-2 But Can Be Resensitized to Venetoclax through Bcl-XL Inhibition.
Journal: Biomolecules
Published: April 27, 2020
Dual dependence on BCL2 and MCL1 in T-cell prolymphocytic leukemia.
Journal: Blood advances
Published: September 03, 2019
Last Updated: 09/26/2026